FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort

BACKGROUND: The role of second-line therapy in gastric cancer patients mostly stemmed from clinical trials with monochemotherapy carried out in Asian countries. Nevertheless, these results cannot be broadly generalized as molecular studies suggested the existence of different sets of deregulated gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Maugeri-Saccà, Marcello, Pizzuti, Laura, Sergi, Domenico, Barba, Maddalena, Belli, Franca, Fattoruso, Silvia Ileana, Giannarelli, Diana, Amodio, Antonella, Boggia, Sara, Vici, Patrizia, Di Lauro, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850248/
https://www.ncbi.nlm.nih.gov/pubmed/24330513
http://dx.doi.org/10.1186/1756-9966-32-67

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850248/
https://www.ncbi.nlm.nih.gov/pubmed/24330513
http://dx.doi.org/10.1186/1756-9966-32-67

Ejemplares similares